Please use this identifier to cite or link to this item:
https://hdl.handle.net/10316/108643
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Vindeirinho, J. | - |
dc.contributor.author | Santiago, A. R. | - |
dc.contributor.author | Cavadas, C | - |
dc.contributor.author | Ambrósio, António F. | - |
dc.contributor.author | Santos, P. F. | - |
dc.date.accessioned | 2023-09-06T10:19:58Z | - |
dc.date.available | 2023-09-06T10:19:58Z | - |
dc.date.issued | 2016 | - |
dc.identifier.issn | 2314-6745 | pt |
dc.identifier.issn | 2314-6753 | pt |
dc.identifier.uri | https://hdl.handle.net/10316/108643 | - |
dc.description.abstract | The neurodegenerative and inflammatory environment that is prevalent in the diabetic eye is a key player in the development and progression of diabetic retinopathy. The adenosinergic system is widely regarded as a significant modulator of neurotransmission and the inflammatory response, through the actions of the four types of adenosine receptors (A1R, A2AR, A2BR, and A3R), and thus could be revealed as a potential player in the events unfolding in the early stages of diabetic retinopathy. Herein, we review the studies that explore the impact of diabetic conditions on the retinal adenosinergic system, as well as the role of the said system in ameliorating or exacerbating those conditions. The experimental results described suggest that this system is heavily affected by diabetic conditions and that the modulation of its components could reveal potential therapeutic targets for the treatment of diabetic retinopathy, particularly in the early stages of the disease. | pt |
dc.language.iso | eng | pt |
dc.publisher | Hindawi | pt |
dc.relation | SFRH/BD/43968/2008 | pt |
dc.relation | PEst- C/SAU/LA0001/2013-201 | pt |
dc.relation | SFRH/BD/51195/2010 | pt |
dc.rights | openAccess | pt |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | pt |
dc.subject.mesh | Adenosine | pt |
dc.subject.mesh | Animals | pt |
dc.subject.mesh | Cellular Microenvironment | pt |
dc.subject.mesh | Diabetic Retinopathy | pt |
dc.subject.mesh | Humans | pt |
dc.subject.mesh | Purinergic P1 Receptor Antagonists | pt |
dc.subject.mesh | Receptors, Purinergic P1 | pt |
dc.subject.mesh | Retina | pt |
dc.subject.mesh | Signal Transduction | pt |
dc.title | The Adenosinergic System in Diabetic Retinopathy | pt |
dc.type | article | - |
degois.publication.firstPage | 4270301 | pt |
degois.publication.lastPage | 8 | pt |
degois.publication.title | Journal of Diabetes Research | pt |
dc.peerreviewed | yes | pt |
dc.identifier.doi | 10.1155/2016/4270301 | pt |
degois.publication.volume | 2016 | pt |
dc.date.embargo | 2016-01-01 | * |
uc.date.periodoEmbargo | 0 | pt |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.grantfulltext | open | - |
item.openairetype | article | - |
item.languageiso639-1 | en | - |
item.fulltext | Com Texto completo | - |
item.cerifentitytype | Publications | - |
crisitem.author.researchunit | CNC - Center for Neuroscience and Cell Biology | - |
crisitem.author.researchunit | CNC - Center for Neuroscience and Cell Biology | - |
crisitem.author.orcid | 0000-0002-7541-7041 | - |
crisitem.author.orcid | 0000-0002-0477-1641 | - |
crisitem.author.orcid | 0000-0002-2225-455X | - |
Appears in Collections: | IIIUC - Artigos em Revistas Internacionais I&D IBILI - Artigos em Revistas Internacionais I&D CNC - Artigos em Revistas Internacionais |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
The-adenosinergic-system-in-diabetic-retinopathyJournal-of-Diabetes-Research.pdf | 1.38 MB | Adobe PDF | View/Open |
Page view(s)
77
checked on Aug 28, 2024
Download(s)
43
checked on Aug 28, 2024
Google ScholarTM
Check
Altmetric
Altmetric
This item is licensed under a Creative Commons License